|

Fasting XTR003/¹⁸F-FDG PET myocardial metabolic imaging Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Sinotau Pharmaceutical Group1

Indications

  • Ischemic Cardiomyopathy1
  • Heart Disease1
  • Heart Failure1

Other1 trial

PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.